4610133302!
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2D226D0009
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Alendronate Sodium Tablets Pre-Solicitation · SPE2D225R0023 · Posted Sep 4, 2025
- Last date to order 8% complete
- IDV ceiling
- $4,457,450.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense-designated Medical Supply Chain awarded a single-award indefinite delivery contract (IDIQ) to Exelan Pharmaceuticals Inc. on June 8, 2026, with a ceiling of $4.46 million and no set-aside. The vehicle runs to an ultimate completion date of June 7, 2031.
The awardee is a foreign-owned pharmaceutical manufacturer and distributor headquartered in Boca Raton, Florida, and the source states that its foreign ownership does not restrict eligibility for federal pharmaceutical procurement. Performance is described at Boca Raton, Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and designated federal delivery points. The source identifies no subcontractors.
The IDIQ traces to a Defense Logistics Agency Troop Support Medical pre-solicitation posted September 4, 2025, for a national requirements contract for Alendronate Sodium Tablets in 35 mg and 70 mg strengths, each in 4-count boxes. The planned requirement serves Department of Defense and Indian Health Service customers through the DLA and VA prime vendor programs. The notice describes a firm-fixed-price requirements-type contract with a one-year base period and four one-year option periods, a potential five-year span, and an unrestricted, fully competitive acquisition under NAICS 325412 and PSC 6505. The notice projected solicitation release for October 2025, with DLA reserving the right to issue before or after that date. Questions go to Courtney Hunter-Stangler at Courtney.Hunter-Stangler@dla.mil. The notice identifies no incumbents and discloses no award values or budget ranges.
The source identifies no task orders issued under this IDIQ.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract SPE2D226D0009?
SPE2D226D0009 was awarded to Exelan Pharmaceuticals Inc. by Medical Supply Chain (Troop Support) on June 8, 2026.
How much is contract SPE2D226D0009 worth?
SPE2D226D0009's own ceiling is $4,457,450.
Who can order from contract SPE2D226D0009?
SPE2D226D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2D226D0009 competed?
The extent of competition for SPE2D226D0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV